Smith Nicholas Conrad
SEC CIK 2009130 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ANRO | Alto Neuroscience, Inc. | CFO, CBO | 24.1K | $125.6K | — | 4 | 2024-02-06 | 2026-03-01 |
Most active insiders at ANRO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Smith Nicholas Conrad | CFO, CBO | — | — |
| 2 | Etkin Amit | Pres AND CEO, Dir | — | — |
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-03 | 2026-03-01 | ANRO | Alto Neuroscience, Inc. | Smith Nicholas Conrad | CFO, CBO | F - Tax | $19.69 | -2,806 | 24.1K | -10% | -$55.3K | |
| M | 2024-04-01 | 2024-03-28 | ANRO | Alto Neuroscience, Inc. | Smith Nicholas Conrad | CFO | P - Purchase | $16.36 | +6,150 | 26.9K | +30% | +$100.6K |
| D | 2024-03-05 | 2024-03-01 | ANRO | Alto Neuroscience, Inc. | Smith Nicholas Conrad | CFO | A - Grant | $0.00 | +19.2K | 20.7K | +1,225% | $0 |
| 2024-02-07 | 2024-02-06 | ANRO | Alto Neuroscience, Inc. | Smith Nicholas Conrad | CFO | P - Purchase | $16.00 | +1,563 | 1,563 | New | +$25.0K |
Purchase Sale Sale after option exercise All abbreviations